Inactive Instrument
Quotes Cerevel Therapeutics Holdings, Inc.
Stocks
CERE
US15678U1280
Biotechnology & Medical Research
Stock exchange
Nasdaq
CERE 44.96 $
+0.74%
679M
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 1 day | +0.74% | ||
| 3 years | +98.15% | ||
| 5 years | +37.91% |
Volumes
marketsCapital turnover ratio
0.02
Float rotation
0.02
Basic data
Market Cap (USD)
8,191,474,701
Number of employees
355
Sales / Employee ()
0
Sales / Employee (USD)
0
Free-Float
93.64%
Free-Float capitalization (USD)
7,670,416,311
Average Daily Capital Traded
1.71%
Indicators
Moving average 5 days
44.6
Moving average 20 days
42.53
Moving average 50 days
41.6
Moving average 100 days
41.89
Price spread / (MMA5)
-0.80%
Price spread / (MMA20)
-5.40%
Price spread / (MMA50)
-7.47%
Price spread / (MMA100)
-6.83%
RSI 9 days
78.72
RSI 14 days
72.45
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.74% | -.--% | -.--% | +98.15% | 8.19B | ||
| +0.79% | -6.16% | +49.32% | +74.50% | 66.34B | ||
| -0.54% | +6.08% | +11.21% | +89.56% | 52.92B | ||
| -0.41% | +3.99% | +6.59% | +72.10% | 54.82B | ||
| +0.74% | +2.75% | +26.31% | +45.29% | 44.09B | ||
| +3.87% | +10.15% | +20.69% | +132.73% | 43.72B | ||
| +7.91% | +4.30% | +263.91% | +602.72% | 42.13B | ||
| -0.40% | +9.85% | +17.04% | +59.17% | 33.96B | ||
| -1.46% | -0.84% | +36.92% | +6.87% | 26.17B | ||
| +0.27% | +5.04% | +35.87% | +25.71% | 23.37B | ||
| Average | +1.14% | +1.67% | +46.79% | +120.68% | 39.57B | |
| Weighted average by Cap. | +1.24% | +1.99% | +50.02% | +127.42% |
Historical Quotes: Cerevel Therapeutics Holdings, Inc.
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 21.86 | 44.99 | |
| 5 years | 19.59 | 46.16 | |
| 10 years | 9 | 46.16 |
Monthly variations
Annual variations
| 2024 | +6.04% | ||
| 2023 | +34.43% | ||
| 2022 | -2.71% | ||
| 2021 | +95.54% | ||
| 2020 | +39.33% |
















